非洲伯基特淋巴瘤B细胞受体高通量测序揭示发病机制线索
对51例原发伯基特淋巴瘤肿瘤(乌干达19例、加纳32例)行免疫球蛋白重链及轻链基因高通量测序,其中41例和46例分别检出克隆性IGH和IGK/IGL重排。仅6/41例克隆性IGH重排肿瘤显示第二IGH等位基因重排证据,提示双等位基因IGHD至IGHJ重排过程常被破坏。多数肿瘤含大量与优势重排差异小于10个核苷酸的IGH和IGK/IGL序列,且IGHV使用富集于健康记忆B细胞中少用的基因,提示伯基特淋巴瘤源自异常B细胞祖细胞且免疫球蛋白位点存在异常突变过程。
要点
- 51例原发伯基特淋巴瘤中41例检出克隆性IGH重排、46例检出克隆性IGK/IGL重排。
- 仅6/41例克隆性IGH重排肿瘤有第二IGH等位基因重排证据,提示双等位基因重排过程常被破坏。
- 肿瘤IGHV使用富集健康记忆B细胞少用的基因,提示异常B细胞祖细胞来源及免疫球蛋白位点异常突变。
核心结论
- 伯基特淋巴瘤可能源自异常B细胞祖细胞,且免疫球蛋白位点在肿瘤细胞中存在异常突变过程。
研究设计与样本
- 对51例原发伯基特淋巴瘤肿瘤(乌干达19例、加纳32例)的基因组DNA行IGH和IGK/IGL位点高通量测序,并对乌干达肿瘤行逆转录聚合酶链反应分析和肿瘤RNA测序以确认和扩展DNA高通量测序结果。
主要发现
- 41例和46例肿瘤分别检出克隆性IGH和IGK/IGL重排。
- 41例克隆性IGH重排肿瘤中仅6例观察到第二IGH等位基因重排证据。
- 多数肿瘤(包括仅含单一优势非表达DJ重排者)含大量与优势重排差异小于10个核苷酸的IGH和IGK/IGL序列。
- 两个伯基特淋巴瘤肿瘤队列的IGHV使用均富集健康受试者记忆B细胞中少用的IGHV基因。
- 公开DNA测序和RNA测序数据显示这些相同IGHV基因在多个独立伯基特淋巴瘤肿瘤队列的优势肿瘤相关IGH重排中过表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Burkitt lymphoma (BL), the most common pediatric cancer in sub-Saharan Africa, is a malignancy of antigen-experienced B lymphocytes. High-throughput sequencing (HTS) of the immunoglobulin heavy (IGH) and light chain (IGK/IGL) loci was performed on genomic DNA from 51 primary BL tumors: 19 from Uganda and 32 from Ghana. Reverse transcription polymerase chain reaction analysis and tumor RNA sequencing (RNAseq) was performed on the Ugandan tumors to confirm and extend the findings from the HTS of tumor DNA. Clonal IGH and IGK/IGL rearrangements were identified in 41 and 46 tumors, respectively. Evidence for rearrangement of the second IGH allele was observed in only 6 of 41 tumor samples with a clonal IGH rearrangement, suggesting that the normal process of biallelic IGHD to IGHJ diversity-joining (DJ) rearrangement is often disrupted in BL progenitor cells. Most tumors, including those with a sole dominant, nonexpressed DJ rearrangement, contained many IGH and IGK/IGL sequences that differed from the dominant rearrangement by < 10 nucleotides, suggesting that the target of ongoing mutagenesis of these loci in BL tumor cells is not limited to expressed alleles. IGHV usage in both BL tumor cohorts revealed enrichment for IGHV genes that are infrequently used in memory B cells from healthy subjects. Analysis of publicly available DNA sequencing and RNAseq data revealed that these same IGHV genes were overrepresented in dominant tumor-associated IGH rearrangements in several independent BL tumor cohorts. These data suggest that BL derives from an abnormal B-cell progenitor and that aberrant mutational processes are active on the immunoglobulin loci in BL cells.
引用
- Lombardo KA, Coffey DG, Morales AJ, et al. High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis. Blood Adv. 2017. PMID: 29296973. doi:10.1182/bloodadvances.2016000794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。